Ken Fisher founded Fisher Investments.
Fisher Asset Management, LLC Holdings · Q1 2026
| Stock | % | Avg. buy price | Estimated gain | Quarter-end price | Last transaction | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Avg. buy price
$100.81
Estimated gain+71.7%Quarter-end price
$173.10
Last transaction
Added· Q1 2026Increased shares by 2.9%
|
|
5.2% | $100.81 | +71.7% | $173.10 | Added· Q1 2026Increased shares by 2.9% | |||||
|
Avg. buy price
$144.61
Estimated gain+75.0%Quarter-end price
$253.09
Last transaction
Added· Q1 2026Increased shares by 2.3%
|
|
4.9% | $144.61 | +75.0% | $253.09 | Added· Q1 2026Increased shares by 2.3% | |||||
|
Avg. buy price
$126.65
Estimated gain+122.2%Quarter-end price
$281.41
Last transaction
Added· Q1 2026Increased shares by 2.5%
|
|
3.8% | $126.65 | +122.2% | $281.41 | Added· Q1 2026Increased shares by 2.5% | |||||
|
Avg. buy price
$277.74
Estimated gain+33.3%Quarter-end price
$370.17
Last transaction
Added· Q1 2026Increased shares by 2.5%
|
|
3.3% | $277.74 | +33.3% | $370.17 | Added· Q1 2026Increased shares by 2.5% | |||||
|
Avg. buy price
$135.42
Estimated gain+52.2%Quarter-end price
$206.15
Last transaction
Added· Q1 2026Increased shares by 1.8%
|
|
2.4% | $135.42 | +52.2% | $206.15 | Added· Q1 2026Increased shares by 1.8% | |||||
|
Avg. buy price
$245.59
Estimated gain+188.5%Quarter-end price
$708.46
Last transaction
Added· Q1 2026Increased shares by 3.0%
|
|
2.3% | $245.59 | +188.5% | $708.46 | Added· Q1 2026Increased shares by 3.0% | |||||
|
Avg. buy price
$127.48
Estimated gain+165.1%Quarter-end price
$337.95
Last transaction
Added· Q1 2026Increased shares by 2.6%
|
|
2.1% | $127.48 | +165.1% | $337.95 | Added· Q1 2026Increased shares by 2.6% | |||||
|
Avg. buy price
$656.38
Estimated gain+101.2%Quarter-end price
$1,320.83
Last transaction
Added· Q1 2026Increased shares by 2.6%
|
|
2.1% | $656.38 | +101.2% | $1,320.83 | Added· Q1 2026Increased shares by 2.6% | |||||
|
Avg. buy price
$372.86
Estimated gain+126.9%Quarter-end price
$845.99
Last transaction
Added· Q1 2026Increased shares by 0.8%
|
|
2.0% | $372.86 | +126.9% | $845.99 | Added· Q1 2026Increased shares by 0.8% | |||||
|
Avg. buy price
$106.93
Estimated gain+58.6%Quarter-end price
$169.63
Last transaction
Added· Q1 2026Increased shares by 2.5%
|
|
1.9% | $106.93 | +58.6% | $169.63 | Added· Q1 2026Increased shares by 2.5% | |||||
|
Avg. buy price
$58.12
Estimated gain+113.8%Quarter-end price
$124.28
Last transaction
Added· Q1 2026Increased shares by 0.9%
|
|
1.7% | $58.12 | +113.8% | $124.28 | Added· Q1 2026Increased shares by 0.9% | |||||
|
Avg. buy price
$183.32
Estimated gain+60.5%Quarter-end price
$294.16
Last transaction
Added· Q1 2026Increased shares by 6.3%
|
|
1.7% | $183.32 | +60.5% | $294.16 | Added· Q1 2026Increased shares by 6.3% | |||||
|
Avg. buy price
$182.06
Estimated gain+70.0%Quarter-end price
$309.51
Last transaction
Added· Q1 2026Increased shares by 6.1%
|
|
1.5% | $182.06 | +70.0% | $309.51 | Added· Q1 2026Increased shares by 6.1% | |||||
|
Avg. buy price
$136.96
Estimated gain+51.1%Quarter-end price
$206.88
Last transaction
Added· Q1 2026Increased shares by 1.9%
|
|
1.5% | $136.96 | +51.1% | $206.88 | Added· Q1 2026Increased shares by 1.9% | |||||
|
Avg. buy price
$401.39
Estimated gain+129.1%Quarter-end price
$919.77
Last transaction
Added· Q1 2026Increased shares by 5.1%
|
|
1.5% | $401.39 | +129.1% | $919.77 | Added· Q1 2026Increased shares by 5.1% | |||||
A
Abbott Laboratories (ABT)
−$1.2B
A
Adobe Inc. (ADBE)
−$1.1B
S
Stryker Corporation (SYK)
−$955M
B
Boston Scientific Corporation (BSX)
−$695M
S
Banco Santander, S.A. (SAN)
−$684M
L
Lumentum Holdings Inc. (LITE)
−$247M
I
Intuit Inc. (INTU)
−$119M
T
T. Rowe Price Group, Inc. (TROW)
−$108M
A
AbbVie Inc. (ABBV)
+$1.9B
A
AstraZeneca PLC (AZN)
New+$1.8B
P
Pfizer Inc. (PFE)
+$1.4B
C
Cisco Systems, Inc. (CSCO)
+$1.1B
N
Novartis AG (NVS)
+$984M
N
NVIDIA Corporation (NVDA)
+$460M
A
Apple Inc. (AAPL)
+$334M
J
JPMorgan Chase & Co. (JPM)
+$304M
B
Banco Bilbao Vizcaya Argentaria, S.A. (BBVA)
−4.2M
I
ING Groep N.V. (ING)
−3.5M
T
Trip.com Group Limited (TCOM)
Exited−2.4M
P
Petróleo Brasileiro S.A. - Petrobras (PBR)
−2.2M
J
Jefferies Financial Group Inc. (JEF)
−2.1M
M
Mitsubishi UFJ Financial Group, Inc. (MUFG)
+2.4MLargest holdings in Q1 2026, sized by their share of the disclosed portfolio. This shows what is owned, not what changed.
Ken Fisher founded Fisher Investments. This page shows Fisher Asset Management's quarterly Form 13F report of certain United States listed long positions, not Fisher's personal account or a client-by-client view. Cash, short positions, private investments, many derivatives, and trades completed before quarter end may be absent.
Profile refreshed July 20, 2026
As of the Q1 2026 filing, Ken Fisher's largest disclosed holdings are NVIDIA Corporation (NVDA), Apple Inc. (AAPL), iShares Tr 7 10yr Tr Bd ETF. The table shows 15 of 1,016 positions by default, with an exact-count control for the remaining rows. Disclosed shares and values remain visible even when a separate market-price estimate is unavailable.
The biggest disclosed buys in Q1 2026 were AbbVie Inc. (ABBV), AstraZeneca PLC (AZN), Pfizer Inc. (PFE), based on the Fisher Asset Management, LLC 13F filing. New positions are marked "new" in the table above.
The biggest reductions in Q1 2026 were Abbott Laboratories (ABT), Adobe Inc. (ADBE), Stryker Corporation (SYK). The filing comparison contains 70 full exits, summarized in the activity view above.
The latest 13F discloses $294.9B across 1,016 positions in Q1 2026. 13F filings cover US-listed long positions only; cash and short positions are not disclosed.
Funds file 13Fs up to 45 days after each quarter ends, so this portfolio reflects Q1 2026, the latest disclosed quarter. The filing date is shown with every table.
Non-rejected, non-superseded SEC Form 13F filings for Fisher Asset Management, LLC provide the Q1 2026 holdings, disclosed values, and filing date shown here. WhoBought prefers filings whose value units validate and labels a sparse filing when validation is unavailable. Industry labels come from the local company classification record.
Performance uses daily closing prices for holdings with available market-price history. It covers the priced share of disclosed value (74%); holdings without sufficient price history are excluded from the calculation.
Ken Fisher founded Fisher Investments in 1979. He stepped down as chief executive in 2016 but remains the firm's executive chairman and co-chief investment officer.
Fisher began the business with $250. What started in 1979 later grew into a large independent investment manager.
He helped define and test the price-to-sales ratio as a stock-valuation tool. Fisher later wrote that the measure had become widely known and was no longer as useful on its own for finding undervalued stocks.
He has written eleven investing books. His Forbes Portfolio Strategy column ran from 1984 through 2017, making him the magazine's longest continuously running columnist.
Fisher went to Cal Poly Humboldt intending to study forestry and graduated with an associate degree in economics in 1972.
No. He left the chief executive role in July 2016 and remains executive chairman and co-chief investment officer.
Yes. He is the son of Philip A. Fisher, the investor and author known for writing Common Stocks and Uncommon Profits.
No. It is Fisher Asset Management's Form 13F portfolio, not Fisher's personal account or an estimate of his wealth.
No. It shows certain US-listed long positions held at quarter end, not client returns, cash, shorts, private investments, or every trade. It is useful for studying disclosed holdings, not reconstructing the whole strategy.